TAGRISSO
Active substance: osimertinib
TABLET, FILM COATED · OSIMERTINIB 80 mg/1
United StatesActive
Marketing holder: AstraZeneca Pharmaceuticals LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- OSIMERTINIB · 80 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-7161-7809-a2de-cc1a16ff47d0,01a12096-d90c-790f-8c0a-ed5933c9e147,01a12096-d934-718d-ab0b-c1a69a36d6c8,01a12096-d93e-7086-8b26-768d775f03e1;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0310-1350
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0310-1350 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0310-1350 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0310-1350 · Verified 2026-10-09 · open in source